CMND Receives Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial
Clearmind Medicine Inc. Common Shares · Now $3.17
+47% in 3d after detection
Post-detection moves
1h
-5.8%
1d
+1.5%
3d
+47%
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS